STVN · Stevanato Group S.p.A.
Market Cap
$5.71B
Shares
273.13M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$20.90
Open$20.96
Day$20.71–21.35
52W close$13.43–27.61
Avg vol 30d444K
Short int1.1M · 0.4% float · 2.4d
Short vol23%
Last earningsAug 4, 2026
DataJul 2021–Sep 2026
Up next
Next earnings call
Nov 22, 2026
Est · unconfirmed
· in 10 wks
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+7.4%
Year over year
Operating margin
16.8%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
0.3%
Trailing 12 months
Shares change YoY
+0.0%
Year over year
Price change (1Y)
-18.9%
Trailing year
Short interest
0.4%
Latest settlement · 2.4 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Strong
Sentiment
Bearish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.8 · calm
Equity put/call 0.60
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+14%
above
Price vs 50-day avg
+2%
above
RSI (14)
50
neutral
MACD trend
Negative
52-week position
53%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−3%
trailing
6-month return
+43%
trailing
YTD return
+4%
this year
Relative strength
+25%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $20 › 200d $18 — 50d above 200d
Institutional flow
Distributing
-7% holders QoQ · +21 funds added
Insider flow
Distributing
Net -$268.3K over 90 days · 100% sells
Short interest
Rising
0.41% of float · ▲ +9.5% MoM · 2.4 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
125 holders — mid 3-yr range
Squeeze score
48
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
47%
annualized · 1-yr
Max drawdown
−51%
past year
ATR
3.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Jun 30, 2026
fiscal year 2026
High-value solutions as % of total company revenue
Initiated
47% – 48%
fiscal 2026
High-value solutions as percent of total company revenue
Initiated
47% – 48%
Adjusted EBITDA margin
Non-GAAP
Initiated
26.8%
full year
Adjusted EBITDA margin
Non-GAAP
26.8%
Prior guidance
period ended
· from the Earnings Call filed Jun 30, 2021
High-value solutions contribution to revenue
· full-year 2021
25% – 26%
Gross revenue attributable to COVID
· full-year 2021
13% – 17%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+14%
Bullish
Price vs 50-day avg
+2%
Bullish
RSI (14)
50
Neutral
MACD trend
Negative
Bearish
52-week position
53%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $20 › 200d $18 — 50d above 200d
Institutional flow
Distributing
-7% holders QoQ · +21 funds added
Insider flow
Distributing
Net -$268.3K over 90 days · 100% sells
Short interest
Rising
0.41% of float · ▲ +9.5% MoM · 2.4 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
125 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $13
Now $21 · 53%
Range high $28
vs 200-day avg +14%
vs 50-day avg +2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
STVN
this stock
Stevanato Group S.p.A.
|
$5.71B | +3.9% | — | — | 0.4% |
|
ISRG
Intuitive Surgical Inc
|
$127.34B | -34.8% | +20.5% | 41.4 | 2.2% |
|
BDX
Becton Dickinson & Co
|
$48.31B | — | +8.2% | — | 3.9% |
|
MDLN
Medline Inc.
|
$42.58B | -22.5% | +11.5% | — | 3.0% |
|
ALC
Alcon Inc
|
$31.95B | -16.2% | +10.5% | — | 3.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| STVN | +1.8% | -2.9% | +43.2% | -2.5% | +3.9% |
| SPY | -1.2% | -1.8% | +17.8% | -0.4% | +12.1% |
| vs SPY | +2.9% | -1.1% | +25.3% | -2.1% | -8.2% |
Capital returns
Latest dividend
$0.062
/ share · ex Jun 11, 2026
Paid (TTM)
$0.062
/ share · 1 payout
Dividend yield (TTM, derived)
— · history filling in
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1849853
CUSIP
T9224W109
13F (30d)
56 filings
56 filers
Visit website
Investor relations